183 related articles for article (PubMed ID: 33031232)
1. Is 68Ga-Prostate-Specific Membrane Antigen PET/CT Superior than 18F-FDG PET/CT for Evaluation of Metastatic Osteosarcoma?
Can C; Gündoğan C; Kömek H
Clin Nucl Med; 2021 Apr; 46(4):e233-e235. PubMed ID: 33031232
[TBL] [Abstract][Full Text] [Related]
2. Metastatic Poorly Differentiated Thyroid Cancer With Heterogeneous Distribution of 18F-FDG, 68Ga-DOTATATE, and 68Ga-PSMA on PET/CT.
Civan C; Isik EG; Simsek DH
Clin Nucl Med; 2021 Apr; 46(4):e212-e213. PubMed ID: 33156050
[TBL] [Abstract][Full Text] [Related]
3. Different Appearances of 3 Malignancies in 68Ga-PSMA-11 Versus 18F-FDG PET/CT.
Weitzer F; Nazerani-Hooshmand T; Aigner RM; Pernthaler B
Clin Nucl Med; 2021 Jul; 46(7):e358-e359. PubMed ID: 34081054
[TBL] [Abstract][Full Text] [Related]
4. 68Ga-PSMA-11 PET/CT for prostate cancer staging and risk stratification in Chinese patients.
Zang S; Shao G; Cui C; Li TN; Huang Y; Yao X; Fan Q; Chen Z; Du J; Jia R; Sun H; Hua Z; Tang J; Wang F
Oncotarget; 2017 Feb; 8(7):12247-12258. PubMed ID: 28103574
[TBL] [Abstract][Full Text] [Related]
5. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
6. Complementary Role of 68Ga-Prostate-Specific Membrane Antigen and 18F-FDG PET/CT for Evaluation of Metastases and Treatment Response in Renal Cell Carcinoma.
Has Simsek D; Civan C; Erdem S; Sanli Y
Clin Nucl Med; 2021 Jul; 46(7):579-581. PubMed ID: 33782292
[TBL] [Abstract][Full Text] [Related]
7. 68Ga-PSMA-HBED-CC PET/CT and 18F-FDG PET/CT in Ewing Sarcoma.
Parihar AS; Sood A; Mittal BR; Kumar R; Singh H; Dhatt SS
Clin Nucl Med; 2020 Jan; 45(1):e57-e58. PubMed ID: 31524682
[TBL] [Abstract][Full Text] [Related]
8. 68Ga-PSMA PET/CT in Osteosarcoma in Fibrous Dysplasia.
Sasikumar A; Joy A; Pillai MRA; Alex TM; Narayanan G
Clin Nucl Med; 2017 Jun; 42(6):446-447. PubMed ID: 28346248
[TBL] [Abstract][Full Text] [Related]
9. Prostate-Specific Membrane Antigen Expression in Patients With Differentiated Thyroid Cancer With Thyroglobulin Elevation and Negative Iodine Scintigraphy Using 68Ga-PSMA-HBED-CC PET/CT.
Verma P; Malhotra G; Meshram V; Chandak A; Sonavane S; Lila AR; Bandgar TR; Asopa RV
Clin Nucl Med; 2021 Aug; 46(8):e406-e409. PubMed ID: 33883490
[TBL] [Abstract][Full Text] [Related]
10. The meta-analysis of the effect of 68Ga-PSMA-PET/CT diagnosis of prostatic cancer compared with bone scan.
Zhao R; Li Y; Nie L; Qin K; Zhang H; Shi H
Medicine (Baltimore); 2021 Apr; 100(15):e25417. PubMed ID: 33847640
[TBL] [Abstract][Full Text] [Related]
11. PET/CT With 68Ga-PSMA and 18F-FDG in Metastatic Adenoid Cystic Carcinoma: Report of 2 Cases.
Isgoren S; Hekimsoy T; Koroglu E; Demir H
Clin Nucl Med; 2022 May; 47(5):e423-e424. PubMed ID: 35234196
[TBL] [Abstract][Full Text] [Related]
12. What Is the Comparative Ability of 18F-FDG PET/CT, 99mTc-MDP Skeletal Scintigraphy, and Whole-body MRI as a Staging Investigation to Detect Skeletal Metastases in Patients with Osteosarcoma and Ewing Sarcoma?
Aryal A; Kumar VS; Shamim SA; Gamanagatti S; Khan SA
Clin Orthop Relat Res; 2021 Aug; 479(8):1768-1779. PubMed ID: 33635285
[TBL] [Abstract][Full Text] [Related]
13. Occult Bone Metastases From Hepatocellular Carcinoma Detected on 68Ga-PMSA PET/CT.
Usmani S; Rasheed R; Al Kandari F; Ahmed N
Clin Nucl Med; 2021 Aug; 46(8):661-663. PubMed ID: 33512948
[TBL] [Abstract][Full Text] [Related]
14. Total-Body
Pomykala KL; Czernin J; Grogan TR; Armstrong WR; Williams J; Calais J
J Nucl Med; 2020 Mar; 61(3):405-411. PubMed ID: 31541035
[TBL] [Abstract][Full Text] [Related]
15. Is there a utility of adding skeletal imaging to 68-Ga-prostate-specific membrane antigen-PET/computed tomography in initial staging of patients with high-risk prostate cancer?
Raju S; Sharma A; Patel C; Sahoo R; Das CJ; Kumar S; Sharma A; Kumar R
Nucl Med Commun; 2020 Nov; 41(11):1183-1188. PubMed ID: 32796451
[TBL] [Abstract][Full Text] [Related]
16. Evidence of Prostate-Specific Membrane Antigen Expression in Metastatic Differentiated Thyroid Cancer Using 68Ga-PSMA-HBED-CC PET/CT.
Verma P; Malhotra G; Agrawal R; Sonavane S; Meshram V; Asopa RV
Clin Nucl Med; 2018 Aug; 43(8):e265-e268. PubMed ID: 29894335
[TBL] [Abstract][Full Text] [Related]
17. Comparison of 68Ga-PSMA-HBED-CC and 18F-FDG PET/CT in the Evaluation of Adenoid Cystic Carcinoma-A Prospective Study.
Shamim SA; Kumar N; Arora G; Kumar D; Pathak A; Thakkar A; Sikka K; Singh CA; Kakkar A; Bhalla AS
Clin Nucl Med; 2023 Nov; 48(11):e509-e515. PubMed ID: 37812520
[TBL] [Abstract][Full Text] [Related]
18. Cerebellar Metastases From Prostate Cancer on 68Ga-PSMA PET/CT.
Chan M; Hsiao E; Turner J
Clin Nucl Med; 2017 Mar; 42(3):193-194. PubMed ID: 28033225
[TBL] [Abstract][Full Text] [Related]
19. Solitary Femoral Nodal Metastasis Identified With 68Ga-Prostate-Specific Membrane Antigen PET/CT.
Hilliar L; Yip JWL; Wong VCK; Le K; Mansberg R
Clin Nucl Med; 2021 Feb; 46(2):173-174. PubMed ID: 33315675
[TBL] [Abstract][Full Text] [Related]
20. 68Ga-PSMA Uptake in Brain Metastasis of Gastric Carcinoma.
Kesim S; Oksuzoglu K
Clin Nucl Med; 2022 Sep; 47(9):e585-e586. PubMed ID: 35930713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
